Eiropas Savienība - latviešu - EMA (European Medicines Agency)

accord healthcare s.l.u. - degarelix acetate - prostatas audzēji - citi hormonu antagonisti un tiem līdzīgas vielas - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - degarelix - prostatas audzēji - endokrīnā terapija - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Latvija - latviešu - Zāļu valsts aģentūra

dr. august wolff gmbh & co. kg arzneimittel, germany - klotrimazols - pesārijs - 100 mg

Latvija - latviešu - Zāļu valsts aģentūra

dr. august wolff gmbh & co. kg arzneimittel, germany - klotrimazols - pesārijs - 200 mg

Latvija - latviešu - Zāļu valsts aģentūra

dr. august wolff gmbh & co. kg arzneimittel, germany - klotrimazols - krēms + pesārijs - 10 mg/g + 100 mg

Latvija - latviešu - Zāļu valsts aģentūra

dr. august wolff gmbh & co. kg arzneimittel, germany - klotrimazols - krēms + pesārijs - 20 mg/g + 200 mg

Latvija - latviešu - Zāļu valsts aģentūra

ferring gmbh, germany - mesalazīns - supozitorijs - 1 g